2008
DOI: 10.1016/j.clinph.2007.11.117
|View full text |Cite
|
Sign up to set email alerts
|

67. Anti-ganglioside antibodies in Korean Guillain–Barré syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…AMAN patients with axonal degeneration tended to show rapid progression, late recovery and poor outcome, whereas AMAN patients with RCB tended to show fast recovery and good outcome. 1,4 RCB was reported in about 45% among patients with AMAN in two recent retrospective studies. 6,7 RCB was observed in 12 patients (70.6%) among 17 patients with AMAN in a study of Korea.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…AMAN patients with axonal degeneration tended to show rapid progression, late recovery and poor outcome, whereas AMAN patients with RCB tended to show fast recovery and good outcome. 1,4 RCB was reported in about 45% among patients with AMAN in two recent retrospective studies. 6,7 RCB was observed in 12 patients (70.6%) among 17 patients with AMAN in a study of Korea.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5] On the other hand, acute motor sensory axonal neuropathy (AMSAN) is a rare disease compared with AMAN, but the pathophysiology and clinical course of AMSAN are reported to be similar to those of AMAN except sensory nerve involvement. Reversible conduction block (RCB) which was known to be associated with a sodium-channel dysfunction in node of Ranvier has been reported in some AMAN patients.…”
mentioning
confidence: 99%